Inventor · disambiguated record
Chris Allen Broka
Also filed as: BROKA CHRIS A · BROKA CHRIS ALLEN
23 granted patents·16 pending applications·410 citations·filing 1993–2024
96Inventor score
Top patents by PatentIndex Score
39 records- 0195US7858632B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2005·Granted Dec 28, 2010·28 cites·30 claims
- 0293US8008313B2Methods of using diaminopyrimidine P2X3 and P2X2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2006·Granted Aug 30, 2011·20 cites·13 claims
- 0392US6143744ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Nov 7, 2000·55 cites·46 claims
- 0492US2025066309A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 0591US5998412ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1998·Granted Dec 7, 1999·52 cites·15 claims
- 0690US8846705B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsBROKA CHRIS ALLEN·Filed 2010·Granted Sep 30, 2014·11 cites·24 claims
- 0790US6376506B1Sulfamide-metalloprotease inhibitorsSYNTEX LLC·Filed 1999·Granted Apr 23, 2002·47 cites·5 claims
- 0889US2025025462A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2024·Application pending·0 cites
- 0988US8524725B2Methods of using diaminopyrimidine as P2X3 and P2X⅔ receptor modulators for treatment of respiratory and gastrointestinal diseasesBROKA CHRIS ALLEN·Filed 2011·Granted Sep 3, 2013·9 cites·13 claims
- 1088US5932595AMatrix metalloprotease inhibitorsSYNTEX INC·Filed 1996·Granted Aug 3, 1999·88 cites·60 claims
- 1187US5405864AChemotherapeutic maleimidesSYNTEX INC·Filed 1993·Granted Apr 11, 1995·31 cites·12 claims
- 1287US2024158356A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2023·Application pending·0 cites
- 1383US6130220ASulfamide-metalloprotease inhibitorsSYNTEX INC·Filed 1999·Granted Oct 10, 2000·30 cites·44 claims
- 1482US2023100975A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2022·Application pending·0 cites
- 1577US9556127B2Diaminopyrimidines as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Jan 31, 2017·1 cites·9 claims
- 1675US7049325B2Quinoline derivatives as anti-inflammatory agentsSYNTEX LLC·Filed 2001·Granted May 23, 2006·9 cites·33 claims
- 1775US2021009531A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 1874US9505726B2Substituted biphenyl amides as P2X3 and P2X2/3 antagonistsROCHE PALO ALTO LLC·Filed 2014·Granted Nov 29, 2016·1 cites·18 claims
- 1974US7074939B2Indole derivatives as anti-inflammatory agentsROCHE PALO ALTO LLC·Filed 2005·Granted Jul 11, 2006·1 cites·6 claims
- 2074US5721267AChemotherapeutic pyrrolocarbazole derivativesSYNTEX INC·Filed 1997·Granted Feb 24, 1998·16 cites·5 claims
- 2174US2021008071A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2020·Application pending·0 cites
- 2273US2020115347A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 2372US2019270713A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2019·Application pending·0 cites
- 2470US2019016688A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 2568US2018141919A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2017·Application pending·0 cites
- 2666US2018311240A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2018·Application pending·0 cites
- 2765US6872744B2Indole derivatives as anti-inflammatory agentsSYNTEX LLC·Filed 2002·Granted Mar 29, 2005·1 cites·5 claims
- 2865US2017096404A1Diaminopyrimidines as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
- 2962US6492394B1Sulfonamide hydroxamatesSYNTEX LLC·Filed 1999·Granted Dec 10, 2002·8 cites·34 claims
- 3062US2013225570A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2013·Application pending·0 cites
- 3160US6844366B2Sulfonamide hydroxamatesSYNTEX LLC·Filed 2002·Granted Jan 18, 2005·2 cites·11 claims
- 3260US2016271131A1Methods of using diaminopyrimidine p2x3 and p2x2/3 receptor modulators for treatment of respiratory and gastrointestinal diseasesROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
- 3359US7410994B2Indole derivatives as anti-inflammatory agentsROCHE PALO ALTO LLC·Filed 2006·Granted Aug 12, 2008·0 cites·8 claims
- 3458US8895589B2Pyridinyl amides as P2X3 and P2X2/3 inhibitorsBROKA CHRIS ALLEN·Filed 2012·Granted Nov 25, 2014·0 cites·16 claims
- 3556US2017057932A1Biphenyl and phenyl-pyridine amides as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2016·Application pending·0 cites
- 3653US8283383B2Biphenyl amides as P2X3 and P2X2/3 antagonistsBROKA CHRIS ALLEN·Filed 2010·Granted Oct 9, 2012·0 cites·16 claims
- 3750US7186840B2Quinoline derivatives as anti-inflammatory agentsROCHE PALO ALTO LLC·Filed 2005·Granted Mar 6, 2007·0 cites·29 claims
- 3848US6787559B2Sulfonamide compoundsSYNTEX LLC·Filed 2002·Granted Sep 7, 2004·0 cites·20 claims
- 3937US2011070190A1Heterocyclic antiviral compoundsROCHE PALO ALTO LLC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chris Allen Broka files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →